LymphedemaV1, PubMed, Corpus, bibRecord, 001252

Safety and efficacy of progressive resistance training in breast cancer: a systematic review and meta-analysis.

Identifieur interne : 001252 ( PubMed/Corpus ); précédent : 001251; suivant : 001253

Safety and efficacy of progressive resistance training in breast cancer: a systematic review and meta-analysis.

Auteurs : Birinder S. Cheema ; Sharon L. Kilbreath ; Paul P. Fahey ; Geoffrey P. Delaney ; Evan Atlantis

Source :

Breast cancer research and treatment [ 1573-7217 ] ; 2014.

RBID : pubmed:25324019

English descriptors

KwdEn :
- Breast Neoplasms (rehabilitation), Exercise Therapy, Female, Humans, Quality of Life, Randomized Controlled Trials as Topic, Resistance Training, Safety.
MESH :
- rehabilitation : Breast Neoplasms.
- Exercise Therapy, Female, Humans, Quality of Life, Randomized Controlled Trials as Topic, Resistance Training, Safety.

Abstract

The purpose of this study was to assess the safety and efficacy of progressive resistance training (PRT) in breast cancer. Randomized controlled trials (RCTs) published to November 2013 that reported on the effects of PRT (>6 weeks) on breast cancer-related lymphedema (BCRL) (incidence/exacerbation, arm volume, and symptom severity), physical functioning (upper and lower body muscular strength), and health-related quality of life (HRQoL) in breast cancer patients were included. Of 446 citations retrieved, 15 RCTs in 1,652 patients were included and yielded five studies on BCRL incidence/exacerbation (N = 647), four studies on arm volume (N = 384) and BCRL symptom severity (N = 479), 11 studies on upper body muscular strength (N = 1,252), nine studies on lower body muscular strength (N = 1,079), and seven studies on HRQoL (N = 823). PRT reduced the risk of BCRL versus control conditions [OR = 0.53 (95% CI 0.31-0.90); I2 = 0%] and did not worsen arm volume or symptom severity (both SMD = -0.07). PRT significantly improved upper [SMD = 0.57 (95% CI 0.37-0.76); I2 = 58.4%] and lower body muscular strength [SMD = 0.48 (95% CI 0.30-0.67); I2 = 46.7%] but not HRQoL [SMD = 0.17 (95% CI -0.03 to 0.38); I2 = 47.0%]. The effect of PRT on HRQoL became significant in our sensitivity analysis when two studies conducted during adjuvant chemotherapy [SMD = 0.30 (95% CI 0.04-0.55), I2 = 37.0%] were excluded. These data indicate that PRT improves physical functioning and reduces the risk of BCRL. Clinical practice guidelines should be updated to inform clinicians on the benefits of PRT in this cohort.

DOI: 10.1007/s10549-014-3162-9
PubMed: 25324019

Links to Exploration step

pubmed:25324019

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Safety and efficacy of progressive resistance training in breast cancer: a systematic review and meta-analysis.</title>
<author><name sortKey="Cheema, Birinder S" sort="Cheema, Birinder S" uniqKey="Cheema B" first="Birinder S" last="Cheema">Birinder S. Cheema</name>
<affiliation><nlm:affiliation>School of Science and Health, University of Western Sydney, Locked Bag 1797, Penrith, NSW, 2751, Australia, b.cheema@uws.edu.au.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kilbreath, Sharon L" sort="Kilbreath, Sharon L" uniqKey="Kilbreath S" first="Sharon L" last="Kilbreath">Sharon L. Kilbreath</name>
</author>
<author><name sortKey="Fahey, Paul P" sort="Fahey, Paul P" uniqKey="Fahey P" first="Paul P" last="Fahey">Paul P. Fahey</name>
</author>
<author><name sortKey="Delaney, Geoffrey P" sort="Delaney, Geoffrey P" uniqKey="Delaney G" first="Geoffrey P" last="Delaney">Geoffrey P. Delaney</name>
</author>
<author><name sortKey="Atlantis, Evan" sort="Atlantis, Evan" uniqKey="Atlantis E" first="Evan" last="Atlantis">Evan Atlantis</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25324019</idno>
<idno type="pmid">25324019</idno>
<idno type="doi">10.1007/s10549-014-3162-9</idno>
<idno type="wicri:Area/PubMed/Corpus">001252</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001252</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Safety and efficacy of progressive resistance training in breast cancer: a systematic review and meta-analysis.</title>
<author><name sortKey="Cheema, Birinder S" sort="Cheema, Birinder S" uniqKey="Cheema B" first="Birinder S" last="Cheema">Birinder S. Cheema</name>
<affiliation><nlm:affiliation>School of Science and Health, University of Western Sydney, Locked Bag 1797, Penrith, NSW, 2751, Australia, b.cheema@uws.edu.au.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kilbreath, Sharon L" sort="Kilbreath, Sharon L" uniqKey="Kilbreath S" first="Sharon L" last="Kilbreath">Sharon L. Kilbreath</name>
</author>
<author><name sortKey="Fahey, Paul P" sort="Fahey, Paul P" uniqKey="Fahey P" first="Paul P" last="Fahey">Paul P. Fahey</name>
</author>
<author><name sortKey="Delaney, Geoffrey P" sort="Delaney, Geoffrey P" uniqKey="Delaney G" first="Geoffrey P" last="Delaney">Geoffrey P. Delaney</name>
</author>
<author><name sortKey="Atlantis, Evan" sort="Atlantis, Evan" uniqKey="Atlantis E" first="Evan" last="Atlantis">Evan Atlantis</name>
</author>
</analytic>
<series><title level="j">Breast cancer research and treatment</title>
<idno type="eISSN">1573-7217</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (rehabilitation)</term>
<term>Exercise Therapy</term>
<term>Female</term>
<term>Humans</term>
<term>Quality of Life</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Resistance Training</term>
<term>Safety</term>
</keywords>
<keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Exercise Therapy</term>
<term>Female</term>
<term>Humans</term>
<term>Quality of Life</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Resistance Training</term>
<term>Safety</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The purpose of this study was to assess the safety and efficacy of progressive resistance training (PRT) in breast cancer. Randomized controlled trials (RCTs) published to November 2013 that reported on the effects of PRT (>6 weeks) on breast cancer-related lymphedema (BCRL) (incidence/exacerbation, arm volume, and symptom severity), physical functioning (upper and lower body muscular strength), and health-related quality of life (HRQoL) in breast cancer patients were included. Of 446 citations retrieved, 15 RCTs in 1,652 patients were included and yielded five studies on BCRL incidence/exacerbation (N = 647), four studies on arm volume (N = 384) and BCRL symptom severity (N = 479), 11 studies on upper body muscular strength (N = 1,252), nine studies on lower body muscular strength (N = 1,079), and seven studies on HRQoL (N = 823). PRT reduced the risk of BCRL versus control conditions [OR = 0.53 (95% CI 0.31-0.90); I2 = 0%] and did not worsen arm volume or symptom severity (both SMD = -0.07). PRT significantly improved upper [SMD = 0.57 (95% CI 0.37-0.76); I2 = 58.4%] and lower body muscular strength [SMD = 0.48 (95% CI 0.30-0.67); I2 = 46.7%] but not HRQoL [SMD = 0.17 (95% CI -0.03 to 0.38); I2 = 47.0%]. The effect of PRT on HRQoL became significant in our sensitivity analysis when two studies conducted during adjuvant chemotherapy [SMD = 0.30 (95% CI 0.04-0.55), I2 = 37.0%] were excluded. These data indicate that PRT improves physical functioning and reduces the risk of BCRL. Clinical practice guidelines should be updated to inform clinicians on the benefits of PRT in this cohort.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25324019</PMID>
<DateCreated><Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>07</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7217</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>148</Volume>
<Issue>2</Issue>
<PubDate><Year>2014</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Breast cancer research and treatment</Title>
<ISOAbbreviation>Breast Cancer Res. Treat.</ISOAbbreviation>
</Journal>
<ArticleTitle>Safety and efficacy of progressive resistance training in breast cancer: a systematic review and meta-analysis.</ArticleTitle>
<Pagination><MedlinePgn>249-68</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s10549-014-3162-9</ELocationID>
<Abstract><AbstractText>The purpose of this study was to assess the safety and efficacy of progressive resistance training (PRT) in breast cancer. Randomized controlled trials (RCTs) published to November 2013 that reported on the effects of PRT (>6 weeks) on breast cancer-related lymphedema (BCRL) (incidence/exacerbation, arm volume, and symptom severity), physical functioning (upper and lower body muscular strength), and health-related quality of life (HRQoL) in breast cancer patients were included. Of 446 citations retrieved, 15 RCTs in 1,652 patients were included and yielded five studies on BCRL incidence/exacerbation (N = 647), four studies on arm volume (N = 384) and BCRL symptom severity (N = 479), 11 studies on upper body muscular strength (N = 1,252), nine studies on lower body muscular strength (N = 1,079), and seven studies on HRQoL (N = 823). PRT reduced the risk of BCRL versus control conditions [OR = 0.53 (95% CI 0.31-0.90); I2 = 0%] and did not worsen arm volume or symptom severity (both SMD = -0.07). PRT significantly improved upper [SMD = 0.57 (95% CI 0.37-0.76); I2 = 58.4%] and lower body muscular strength [SMD = 0.48 (95% CI 0.30-0.67); I2 = 46.7%] but not HRQoL [SMD = 0.17 (95% CI -0.03 to 0.38); I2 = 47.0%]. The effect of PRT on HRQoL became significant in our sensitivity analysis when two studies conducted during adjuvant chemotherapy [SMD = 0.30 (95% CI 0.04-0.55), I2 = 37.0%] were excluded. These data indicate that PRT improves physical functioning and reduces the risk of BCRL. Clinical practice guidelines should be updated to inform clinicians on the benefits of PRT in this cohort.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheema</LastName>
<ForeName>Birinder S</ForeName>
<Initials>BS</Initials>
<AffiliationInfo><Affiliation>School of Science and Health, University of Western Sydney, Locked Bag 1797, Penrith, NSW, 2751, Australia, b.cheema@uws.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kilbreath</LastName>
<ForeName>Sharon L</ForeName>
<Initials>SL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Fahey</LastName>
<ForeName>Paul P</ForeName>
<Initials>PP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Delaney</LastName>
<ForeName>Geoffrey P</ForeName>
<Initials>GP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Atlantis</LastName>
<ForeName>Evan</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017418">Meta-Analysis</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>10</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Breast Cancer Res Treat</MedlineTA>
<NlmUniqueID>8111104</NlmUniqueID>
<ISSNLinking>0167-6806</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005081" MajorTopicYN="Y">Exercise Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055070" MajorTopicYN="Y">Resistance Training</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012449" MajorTopicYN="N">Safety</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>10</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>10</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>10</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>7</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25324019</ArticleId>
<ArticleId IdType="doi">10.1007/s10549-014-3162-9</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001252 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001252 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:25324019
   |texte=   Safety and efficacy of progressive resistance training in breast cancer: a systematic review and meta-analysis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:25324019" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Safety and efficacy of progressive resistance training in breast cancer: a systematic review and meta-analysis.

Safety and efficacy of progressive resistance training in breast cancer: a systematic review and meta-analysis.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki